Pexelizumab - CAS 219685-93-5

Pexelizumab (h5G1.1-SC), a humanized scFv monoclonal antibody, targets the C5 complement component, thereby inhibiting apoptosis and leukocyte infiltration. It is utilized in researching cerebral ischemia-reperfusion (IR) injury and myocardial infarction [1] [2].

Apoptosis, Complement System

Apoptosis, Immunology/Inflammation

219587

-20°C

Ice Packs

Inhibitory Antibodies